Journal article

Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight

PG Davis, LW Doyle, AL Rickards, EA Kelly, GW Ford

JOURNAL OF PAEDIATRICS AND CHILD HEALTH | WILEY | Published : 2000

Abstract

OBJECTIVES: Methylxanthines, including theophylline, have been used extensively and successfully to treat apnoea in preterm infants. However, long-term consequences of such therapy are largely unknown. The aim of this study was to determine the relationship between theophylline therapy and outcome at 14 years of age in surviving preterm children of birthweight < 1501 g. METHODOLOGY: The subjects of this study were 154 consecutive survivors with birthweights < 1501 g born from 1 October 1980 to 31 March 1982; 130 (84.4%) were assessed at 14 years of age. Outcomes included motor function, psychological test scores, and growth. RESULTS: Of the 130 children assessed, 69 (53.1%) had been exposed ..

View full abstract